| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/25/2001 | EP1117406A1 Antibiotic compositions for treatment of the eye, ear and nose |
| 07/25/2001 | EP1117402A2 Antibiotic compositions for treatment of the eye, ear and nose |
| 07/25/2001 | EP1117401A2 Antibiotic compositions for treatment of the eye, ear and nose |
| 07/25/2001 | EP1117398A2 A method for treating inflammatory diseases by administering a thrombin inhibitor |
| 07/25/2001 | EP1117296A1 Combination of bisphosphonate and tetracycline |
| 07/25/2001 | EP0854860B1 A new family of compounds having anti-inflammatory and anti-viral activity and compositions of these, alone and in combination with reverse transcriptase inhibitors, for inhibiting, preventing or eliminating viral replication and methods of using same |
| 07/25/2001 | EP0794955B1 Hindered n-oxide esters of rapamycin and their use as medicaments |
| 07/25/2001 | EP0783501B9 pyrimidone derivatives with antifungal activity |
| 07/25/2001 | CN1305589A Improved immunodiagnostic assays using reducing agents |
| 07/25/2001 | CN1305526A Gene coding for heliomicine and use thereof |
| 07/25/2001 | CN1305496A Cyclic somatostatin analogs |
| 07/25/2001 | CN1305493A Novel cyclosporins |
| 07/25/2001 | CN1305484A 3-(2-oxo[1,3']bihyrrolidinyl-3-ylidenemethyl)-cephems |
| 07/25/2001 | CN1305471A Dihydropyrimidines |
| 07/25/2001 | CN1305465A Aryl alkanoylpyridazines |
| 07/25/2001 | CN1305464A Heterocyclic compounds and methods to treat cardiac failure and other disorders |
| 07/25/2001 | CN1305458A Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics |
| 07/25/2001 | CN1305386A Enhancement of antibody-cytokine fusion protein mediated immune responses by co-administration with angiogenesis inhibitor |
| 07/25/2001 | CN1305382A Use of PEG-IFN-alpha and triazole nucleoside for treatment of chronic hepatitis C |
| 07/25/2001 | CN1305374A Oxazolidinones to treat eye infections |
| 07/25/2001 | CN1304930A Arylsulfurylisooximino acid derivative |
| 07/25/2001 | CN1304768A Liquid medicine for beriberi |
| 07/25/2001 | CN1304767A Plaster for treating infantile parotitis and its preparing process |
| 07/25/2001 | CN1304735A Medicine for curing chronic colitis |
| 07/25/2001 | CN1304726A Application of peimin A in preparing medicine to treat drug-resistant bacterial infective diseases |
| 07/25/2001 | CN1304725A Antibacterial cephalosporin composition |
| 07/25/2001 | CN1304722A Medicinal composition for treating AIDS and its application |
| 07/25/2001 | CN1304721A Anti-AIDS medicine composition and its application |
| 07/25/2001 | CN1068878C Sulfonamide derivatives of azolones anti-helicobacter agents |
| 07/25/2001 | CN1068789C Tuberculosis treating medicine and its compounding process |
| 07/24/2001 | US6265604 (R)-3-hydroxy-3-(2-phenylethyl)-hexanoic acid derivatives |
| 07/24/2001 | US6265583 Cyclic sulfone containing retroviral protease inhibitors |
| 07/24/2001 | US6265567 Isolated FrpB nucleic acid molecule |
| 07/24/2001 | US6265536 Cyclic hexapeptides having antibiotic activity |
| 07/24/2001 | US6265434 Antiinflammatory agents |
| 07/24/2001 | US6265396 β-lactam compounds and process for preparing the same |
| 07/24/2001 | US6265395 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment |
| 07/24/2001 | US6265394 Especially useful in the treatment of diseases caused by methicillin-resistant staphylococcus aureus. |
| 07/24/2001 | US6265377 Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
| 07/24/2001 | US6265188 Nucleotide sequence coding a enzymatic polypeptide; for use as a wound healing agent; for prevention of bacterial infection |
| 07/24/2001 | US6265184 Polynucleotides encoding chemokine receptor 88C |
| 07/24/2001 | US6265183 Direct molecular cloning of foreign genes into poxviruses and methods for the preparation of recombinant proteins |
| 07/24/2001 | US6265178 Incubating potential inhibitor with solubilized and purified monoamine oxidase in a buffer solution, adding 1-methyl-4-(1-methyl-2-pyrryl)-1,2,3,6-tetrahydropyridine, determining monoamine oxidase inhibitory activity |
| 07/24/2001 | US6264958 Polynucleotide |
| 07/24/2001 | US6264957 Product of infectious respiratory syncytial virus from cloned nucleotide sequences |
| 07/24/2001 | US6264955 Ferrichrome transport ATP-binding protein |
| 07/24/2001 | US6264954 Immunogenic peptide |
| 07/24/2001 | US6264952 Method for protecting a mammalian host against infection by Brucella |
| 07/24/2001 | US6264947 Genetic engineering; therapy for cancer, autoimmune diseases, reproduction, antiinflammatory agents |
| 07/24/2001 | US6264917 Targeted ultrasound contrast agents |
| 07/24/2001 | CA2285266C Extended release formulations of erythromycin derivatives |
| 07/24/2001 | CA2261732C Preparation of crystal form ii of clarithromycin |
| 07/24/2001 | CA2230303C Polymorphs of the prodrug 6-n-(l-ala-l-ala)-trovafloxacin |
| 07/24/2001 | CA2218503C Arylsulfonyl hydroxamic acid derivatives |
| 07/24/2001 | CA2193454C Bioadhesive pharmaceutical composition for the controlled release of active ingredients |
| 07/24/2001 | CA2111974C Carbapenem derivatives |
| 07/24/2001 | CA2092652C Antiherpes peptide derivatives having a ureido n-terminus |
| 07/24/2001 | CA2066191C Tricyclic ¬6,5,5|/¬6,6,5|-fused oxazolidinone antibacterial agents |
| 07/19/2001 | WO2001051673A1 Methods and compositions for inhibition of membrane fusion-associated events, including hiv transmission |
| 07/19/2001 | WO2001051645A1 Obg3 globular head and uses thereof for decreasing body mass |
| 07/19/2001 | WO2001051641A1 Irak-4: compositions and methods of use |
| 07/19/2001 | WO2001051638A2 Drug metabolizing enzymes |
| 07/19/2001 | WO2001051608A2 Hybrid cells obtainable from antigen presenting cells |
| 07/19/2001 | WO2001051603A2 Pharmaceutical composition and method of using the same |
| 07/19/2001 | WO2001051530A1 Lowly irritant high-molecular antimicrobial agent |
| 07/19/2001 | WO2001051510A2 G-csf conjugates |
| 07/19/2001 | WO2001051499A1 METHODS FOR SYNTHESIS OF α-D-GAL (1→3) GAL-CONTAINING OLIGOSACCHARIDES |
| 07/19/2001 | WO2001051485A1 Arylsulfonic acid salts of pyrimidine-based antiviral agents |
| 07/19/2001 | WO2001051482A1 Extraction of flavonoids |
| 07/19/2001 | WO2001051479A2 Tricyclic compounds with antiviral activity |
| 07/19/2001 | WO2001051473A1 1,2-diaryl benzimidazoles for treating illnesses associated with a microglia activation |
| 07/19/2001 | WO2001051465A1 Tetramic acid derivatives for use in medicine and food technology |
| 07/19/2001 | WO2001051464A1 Novel vitamin d analogues |
| 07/19/2001 | WO2001051462A1 INHIBITORS OF THE ICE/Ced-3 FAMILY OF CYSTEINE PROTEASES |
| 07/19/2001 | WO2001051456A2 Antibacterial agents |
| 07/19/2001 | WO2001051196A1 Templating of solid particles by polymer multilayers |
| 07/19/2001 | WO2001051082A1 Composition of antigen and glycolipid adjuvant sublingual administration |
| 07/19/2001 | WO2001051081A1 In vivo ctl elicitation by heat shock protein fusion proteins maps to a discrete atp binding domain and is cd4+ t cell-independent |
| 07/19/2001 | WO2001051080A2 Methods and compositions for obtaining disease protection for animals |
| 07/19/2001 | WO2001051079A1 Antigen-specific ige antibody production inhibitors |
| 07/19/2001 | WO2001051073A2 The parenteral use of bacterial phage associated lysing enzymes for the therapeutic treatment of bacterial infections |
| 07/19/2001 | WO2001051061A1 Derivatives of polyene macrolides and preparation and use thereof |
| 07/19/2001 | WO2001051059A1 Processes for preparing clarithromycin polymorphs |
| 07/19/2001 | WO2001051014A1 Pharmaceutical and cosmetic carrier or composition for topical application |
| 07/19/2001 | WO2001051003A2 Use of lipid conjugates in the treatment of disease |
| 07/19/2001 | WO2001050987A2 Treatment of hepatitis c using hyperthermia |
| 07/19/2001 | WO2001050873A1 Thickened oil compositions of edible oil |
| 07/19/2001 | WO2001005969A3 Electron transfer proteins |
| 07/19/2001 | WO2001005392A3 Method for treating chronic pain using mek inhibitors |
| 07/19/2001 | WO2001004297A3 Human proteins having hydrophobic domains and dnas encoding these proteins |
| 07/19/2001 | WO2001004271A3 Respiratory syncytial viruses expressing immune modulatory molecules |
| 07/19/2001 | WO2000077043A3 Dna vaccines for pets and sport animals |
| 07/19/2001 | WO2000073324A3 Modulation of gene expression in gastrointestinal inflammation |
| 07/19/2001 | WO2000069891A3 Previns as specific inhibitors and therapeutic agents for botulinum toxin b and tetanus neurotoxins |
| 07/19/2001 | WO2000064485A9 Specifically targeted catalytic antagonists and uses thereof |
| 07/19/2001 | WO2000055321B1 Vertebrate protein slit, dna sequence encoding it and uses thereof |
| 07/19/2001 | WO2000025808A9 Inhibition of differentiation of cytotoxic t-cells by p-selectin ligand (psgl) antagonists |
| 07/19/2001 | WO2000009616A8 Biologically active fraction of vegetable melanin, process for its production and its use |
| 07/19/2001 | US20010008946 Therapeutic nucleosides |
| 07/19/2001 | US20010008939 Also useful in treating viral infections; antiprotozoa (plasmodium) activity |